Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa

Ítems similars

• HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV)
  per: Meiring, Susan, et al.
  Publicat: (2016)
• Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003–2013
  per: von Mollendorf, Claire, et al.
  Publicat: (2016)
• The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults
  per: Feldman, Charles, et al.
  Publicat: (2020)
• Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa
  per: Tempia, Stefano, et al.
  Publicat: (2015)
• Can pneumococcal meningitis surveillance be used to assess the impact of pneumococcal conjugate vaccine on total invasive pneumococcal disease? A case-study from South Africa, 2005–2016
  per: Kleynhans, Jackie, et al.
  Publicat: (2019)